Loading clinical trials...
Loading clinical trials...
In an effort to allow patients continued access to vorinostat outside of the base study, patients that are actively receiving study medication will discontinue from this study and receive vorinostat v...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Merck Sharp & Dohme LLC
NCT04998331 · Hodgkin Disease, Lymphoma, T-Cell, Cutaneous
NCT02836886 · Lymphoma, T-Cell, Cutaneous, Sézary Syndrome
NCT03789864 · Lymphoma, T-Cell, Cutaneous, Mycosis Fungoides
NCT05137847 · Lymphoma, T-cell, Peripheral, Lymphoma, T-cell, Cutaneous
NCT03192202 · Lymphoma, T-Cell, Cutaneous
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions